|
News & press
Conference
February
22, 2008
Clinical Neurosciences 2008 "A fine line : depression to suicide" -
Vancouver, BC
13
Mars 2008
Conférence Neurosciences : essor et enjeux - ENS Paris,
France
26
au 28 Mars 2008
First European Synapse Meeting - Bordeaux, France
April
5 - 10, 2008
10th International Neuroscience winter conference - Austria
April
27 - May 1, 2008
ARVO 2008 Annual Meeting - Fort Lauderdale, Florida
May
7 - 11, 2008
Society of Applied Neuroscience Annual conference - Seville,
Spain
July
12 - 16, 2008
FENS - Forum of European Neuroscience - Geneva, Switzerland
November
15 - 19, 2008
38th annual meeting of the society for Neuroscience - Washington,
DC
News
 Call
for teams
See
the announcement
Propositions
of Theses of Inserm U583
See
the announcement
Propositions
of Theses of Inserm U844
See
the announcement 1
See the announcement 2
See the announcement 3
PhD
position September 2010 Team 5 INM
See
the announcement
Researcher
position September 2010 Sensorion
See
the announcement
Recent
discoveries
1st clinical trial in acute traumatic
deafness. A clinical trial was performed in Munich,
on December 31, 2005, to treat the patients with an acute
acoustic trauma (shootings of fireworks, discotheques). The
patients received a trans-tympanic application of a new active
product, which was conceived and tested by the team of Pr
Jean-Luc Puel (team 02) of the INM. The team showed that this
product allows a better recovery after the trauma and that
it protects from the auditory loss. The trial was conducted
by Auris Medical, a company whose goal is to develop new drugs
for the auditory deficits.
INM:
reference center
the ophthalmologic and ENT consultations
joined to form a Research Center for Rare Diseases: “inherited
sensory defects”.For more than 10 years, teams
have worked on the sensory rare diseases in Montpellier. On
November 19, 2004, the ministry for Health and Social Protection
designated 34 centers of reference for the rare diseases.
The center of reference for the inherited sensory defects,
located in Montpellier is one of the selected centers.
|
